Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

250
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
250
Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

351
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
351
Drug Delivery: Overview01:16

Drug Delivery: Overview

270
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
270
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

480
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
480

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy.

International journal of molecular sciences·2026
Same author

A Pharmacovigilance Study of Immune Checkpoint Inhibitor-Associated Cholangitis: Insights From the FDA Adverse Event Reporting System.

Hepatology research : the official journal of the Japan Society of Hepatology·2025
Same author

Development and validation of an interpretable machine learning model for early prediction in patients with diabetes and sepsis.

Scientific reports·2025
Same author

Safety evaluation of deucravacitinib: a real-world analysis based on the FDA adverse event reporting system database.

International journal of clinical pharmacy·2025
Same author

Gastric-type endocervical adenocarcinoma in situ as the presenting feature in a mosaic STK11 pathogenic variant carrier with a Peutz-Jeghers syndrome child.

Familial cancer·2025
Same author

Single-cell RNA sequencing reveals the intra-tumoral heterogeneity and immune microenvironment of small cell carcinoma of the ovary, hypercalcemic type.

Journal of ovarian research·2025

相关实验视频

Updated: May 24, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.6K

通过基于层次网络的分子通信系统优化向药物输送.

Haowen Tan, Yue Sun, Yifan Chen

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |March 5, 2025
    PubMed
    概括

    本研究介绍了一种用于向药物输送的新型分子通信 (MC) 系统,将血管中的纳米粒子运动转化为网络信息. 该系统可实现血管网络拓提取,并通过网络层调整优化药物输送.

    科学领域:

    • 生物医学工程 生物医学工程
    • 网络科学 网络科学
    • 纳米技术 纳米技术

    背景情况:

    • 目前的分子通信 (MC) 研究主要集中在物理层.
    • 高效的向药物输送仍然是纳米医学的一个重大挑战.
    • 了解和建模复杂的血管网络对于有效的药物输送至关重要.

    研究的目的:

    • 开发一个创新的MC系统,以实现高效的向药物输送.
    • 专注于MC的网络层,将药物动力学过程抽象到虚拟网络中.
    • 通过调整血管网络中的网络应用层参数来优化药物输送.

    主要方法:

    • 在血管网络中抽象药物递送药理动力学,将其转化为分层路由网络.
    • 建模纳米粒子运动作为虚拟网络内的信息传输.
    • 使用拓推断算法和定义的成功传输速率参数.

    主要成果:

    • 证明了将拓推理算法应用于血管网络的可行性.
    • 使用MC参数成功提取了血管网络拓.
    • 通过分层网络方法验证了在生物环境中采用断层扫描技术的潜力.

    结论:

    更多相关视频

    Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
    10:16

    Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

    Published on: February 8, 2017

    7.5K
    Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
    07:25

    Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

    Published on: August 18, 2023

    1.5K

    相关实验视频

    Last Updated: May 24, 2025

    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
    14:20

    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

    Published on: June 13, 2014

    16.6K
    Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
    10:16

    Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

    Published on: February 8, 2017

    7.5K
    Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
    07:25

    Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

    Published on: August 18, 2023

    1.5K
    • 拟议的MC系统为优化向药物输送提供了一种新的方法.
    • 网络中心的MC模型有效地处理了血管网络的复杂性.
    • 这项研究通过改进药物输送系统,为先进的治疗干预开辟了新的可能性.